IL6 and cancer: The other pathways of upregulation in multiple cancer types are allograft rejection (n = 28), IL‐6/JAK/STAT3 signalling (n = 24), inflammatory response (n = 23), ROS pathway (n = 22) and TNF‐α signalling through NF‐kB (n = 14).